SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 323 filers reported holding SEATTLE GENETICS INC in Q3 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,411,000 | +10.3% | 7,210 | -4.2% | 0.11% | -2.7% |
Q2 2020 | $1,279,000 | +23.1% | 7,525 | -16.4% | 0.11% | -5.1% |
Q1 2020 | $1,039,000 | -4.2% | 9,002 | -5.2% | 0.12% | +12.4% |
Q4 2019 | $1,085,000 | +33.8% | 9,500 | 0.0% | 0.10% | +20.7% |
Q3 2019 | $811,000 | +23.4% | 9,500 | 0.0% | 0.09% | +24.3% |
Q2 2019 | $657,000 | -1.9% | 9,500 | +3.8% | 0.07% | -5.4% |
Q1 2019 | $670,000 | +74.0% | 9,150 | +34.6% | 0.07% | +45.1% |
Q4 2018 | $385,000 | -5.9% | 6,800 | -12.4% | 0.05% | -12.1% |
Q4 2016 | $409,000 | -45.9% | 7,760 | -44.6% | 0.06% | -47.3% |
Q3 2016 | $756,000 | +17.2% | 13,995 | -12.4% | 0.11% | +17.0% |
Q2 2016 | $645,000 | +0.5% | 15,970 | -12.7% | 0.09% | -1.1% |
Q1 2016 | $642,000 | -41.6% | 18,295 | -25.3% | 0.10% | -47.2% |
Q4 2015 | $1,100,000 | +12.6% | 24,500 | -3.3% | 0.18% | +5.9% |
Q3 2015 | $977,000 | -19.4% | 25,325 | +1.1% | 0.17% | -14.1% |
Q2 2015 | $1,212,000 | +34.4% | 25,040 | -1.9% | 0.20% | +27.7% |
Q1 2015 | $902,000 | -39.5% | 25,515 | -45.0% | 0.16% | -40.6% |
Q4 2014 | $1,490,000 | -12.6% | 46,375 | +1.1% | 0.26% | -19.4% |
Q3 2014 | $1,705,000 | +26.6% | 45,865 | +30.3% | 0.32% | +5.5% |
Q2 2014 | $1,347,000 | +58.5% | 35,210 | +88.7% | 0.31% | +52.7% |
Q1 2014 | $850,000 | – | 18,660 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |